Recombinant protein diphtheria toxoid. Medical search. Frequent questions

Toxoid vaccines that use a toxin (harmful product) made by the germ. (medlineplus.gov)
toxoid vaccines, which use a toxin made by the disease-causing germ. (ocrc.net)
The aim of the research was to compare in vitro characteristics of reception of the natural diphtheria toxin - DT and its nontoxic recombinant analogs - toxoids. (kiev.ua)
For assessing ligand-receptor interaction the method of immunoenzyme analysis and ELISA was used, where the bonding layer recombinant analogues of diphtheria toxin cell receptor HB-EGF from sensitive and resistant to the toxin of the organisms were served. (kiev.ua)
According to the results of ELISA the natural diphtheria toxin, in contrast to recombinant toxoids - CRM197, and B subunit, interacted with mouse HB-EGF with a very low affinity. (kiev.ua)
While human HB-EGF with an equally high affinity connected as toxoids as native diphtheria toxin. (kiev.ua)
Therefore, the analyzed recombinant analogs of toxin obtained in E. coli cells did not reproduce in full measure the receptor specificity of the natural toxin, which should be considered in the case of using these proteins as biotech products. (kiev.ua)
1. Collier R. J. Diphtheria toxin: mode of action and structure. (kiev.ua)
2. Naglich J. G., Metherall J. E., Russell D. W., Eidels L. Expression cloning of a diphtheria toxin receptor: identity with a heparin-binding EGF-like growth factor precursor. (kiev.ua)
6. Cha J. H., Brooke J. S., Eidels L. Toxin binding site of the diphtheria toxin receptor: loss and gain of diphtheria toxin binding of monkey and mouse heparin-binding, epidermal growth factor-like growth factor precursors by reciprocal site-directed mutagenesis. (kiev.ua)
7. Morris R. E., Saelinger C. B. Diphtheria toxin does not enter resistant cells by receptor-mediated endocytosis. (kiev.ua)
8. Mitamura T., Higashiyama S., Taniguchi N., Klagsbrun M., Mekada E. Diphtheria toxin binds to the epidermal growth factor (EGF)-like domain of human heparin-binding EGF-like growth factor/diphtheria toxin receptor and inhibits specifically its mitogenic activity. (kiev.ua)
9. Mitamura T., Umata T., Nakano F., Shishido Y., Toyoda T., Itai A., Kimura H., Mekada E. Structure-function analysis of the diphtheria toxin receptor toxin binding site by site-directed mutagenesis. (kiev.ua)
10. Moehring T. J., Moehring J. M . Interaction of diphtheria toxin and its active subunit, fragment A, with toxin-sensitive and toxin-resistant cells. (kiev.ua)
11. El Hage T., Decottignies P., Authier F . Endosomal proteolysis of diphtheria toxin without toxin translocation into the cytosol of rat liver in vivo. (kiev.ua)
12. Heagy W. E., Neville D. M. J . Kinetics of protein synthesis inactivation by diphtheria toxin in toxin-resistant L cells. (kiev.ua)
13. Didsbury J. R., Moehring J. M., Moehring T. J. Binding and uptake of diphtheria toxin by toxin-resistant Chinese hamster ovary and mouse cells. (kiev.ua)
14. Labyntsev A. I., Korotkevich N. V., Kaberniuk A. A., Romaniuk S. I., Kolybo D. V., Komisarenko S. V. Interaction of diphtheria toxin B subunit with sensitive and insensitive mammalian cells. (kiev.ua)
15. Kaberniuk A. A., Labyntsev A. I., Kolybo D. V., Oliinyk O. S., Redchuk T. A., Korotkevych N. V., Gorchev V. F., Karakhim S. O., Komisarenko S. V. Fluorescent derivatives of diphtheria toxin subunit B and their interaction with Vero cells. (kiev.ua)
16. Labyntsev A. J., Korotkevych N. V., Manoilov K. J., Kaberniuk A. A., Kolybo D. V., Komisarenko S. V. Recombinant fluorescent models for studying the diphtheria toxin. (kiev.ua)
Overview of Immunization Immunity can be achieved Actively by using antigens (eg, vaccines, toxoids) Passively by using antibodies (eg, immune globulins, antitoxins) A toxoid is a bacterial toxin that has been modified. (msdmanuals.com)
Using chemicals or heat, toxoid vaccines contain an inactivated toxin that has been rendered harmless. (verv.com)

The efficacy of a newly generated Vibrio cholerae ghost (rVCG)-based subunit vaccine harboring the N-terminal portion of the Cab Pmp18D protein (rVCG-Pmp18.3) in preventing Cab-induced abortion or neonatal mortality was evaluated in pregnant mice. (bvsalud.org)
3. Subunit, Recombinant, or Conjugate Vaccines: These vaccines contain specific proteins or fragments of pathogens that stimulate an immune response. (cims.org)
subunit, recombinant, polysaccharide, and conjugate vaccines, which use specific parts of the germ in question (such as protein or sugar). (ocrc.net)
Generally, pathogen products used in subunit vaccines include purified or recombinant protein-inactivated bacterial toxins, or polysaccharides present on surface capsules. (medicaltrend.org)

Vaxelis includes antigens for diphtheria, tetanus, pertussis (whooping cough), and poliomyelitis from Sanofi and antigens for H. influenzae type b and hepatitis B from Merck. (advocatehealthyu.com)
In addition, non-replicating mRNAs can be used to produce RNA-related vaccines that involve mRNA sequences encoding pathogen-specific proteins (antigens) in host cells. (medicaltrend.org)
In non-replicating vaccines, immunogens used to induce pathogen-specific host immune responses include killed pathogens, purified or synthesized pathogen structures or recombinant pathogen products as antigens. (medicaltrend.org)
Conjugate vaccines in which polysaccharide antigens are covalently linked to carrier proteins belong to the most effective and safest vaccines against bacterial pathogens. (biomedcentral.com)
Two different periplasmic carrier proteins, AcrA from C. jejuni and a toxoid form of Pseudomonas aeruginosa exotoxin were glycosylated with Shigella O antigens in E. coli . (biomedcentral.com)
Menactra vaccine contains N meningitidis serogroup 8 A, C, Y and W-135 capsular polysaccharide antigens individually conjugated to diphtheria toxoid 9 protein. (precisionvaccinations.com)

Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed, Inactivated Poliovirus, Haemophilus b Conjugate (Meningococcal Protein Conjugate), and Hepatitis B (Recombinant) Vaccine. (cdc.gov)
BRIDGEWATER, N.J. and KENILWORTH, N.J. - December 26, 2018 -The U.S. Food and Drug Administration has approved Vaxelis™ (Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed, Inactivated Poliovirus, Haemophilus b Conjugate [Meningococcal Protein Conjugate] and Hepatitis B [Recombinant] Vaccine) for use in children from 6 weeks through 4 years of age (prior to the 5th birthday). (advocatehealthyu.com)
Vaxelis is a vaccine indicated for active immunization to prevent diphtheria, tetanus, pertussis, poliomyelitis, hepatitis B, and invasive disease due to Haemophilus influenzae type b. (advocatehealthyu.com)
These components are the Haemophilus influenzae type b capsular polysaccharide [polyribosylribitol phosphate (PRP)] that is covalently bound to an outer membrane protein complex (OMPC) of Neisseria meningitidis and hepatitis B surface antigen (HBsAg) from recombinant yeast cultures. (theodora.com)
Diphtheria, Tetanus, Pertussis, Hepatitis B and Haemophilus influenzae type b Conjugate Vaccine Adsorbed as supplied by Serum the parent's history with respect to possible sensitivity and any previous adverse reactions to the vaccine or similar vaccines. (who.int)
B y la Haemophilus influenzae tipo b, en la forma suministrada por el Serum Institute of India Pvt. (who.int)
Special care should be taken to ensure that the polisacáridos capsulares, altamente purificados, no-infecciosos de Haemophilus influenzae tipo b (Hib), químicamente conjugados a using recombinant DNA procedures. (who.int)
The development of children's immune systems to combat major illnesses and diseases like measles, diphtheria, poliomyelitis, and Haemophilus influenzae type b is greatly aided by pediatric immunizations (Hib). (verifiedmarketresearch.com)

Tetanus and diphtheria toxoids require booster doses to maintain protective antibody concentrations ( 1 ). (cdc.gov)
These are useful for tetanus and diphtheria prevention. (ocrc.net)
A stale combination of tetanus and diphtheria toxoids and pertussis bacilli have been killed. (pcweb.info)

In RNA vaccines, mRNA is used as a template for the endogenous synthesis of the target pathogenic protein (antigen). (medicaltrend.org)
By the mid-1980s, the second generation of hepatitis B vaccines became commercially available- Recombivax-HB and Engerix-B . These vaccines utilized recombinant DNA technology to express a nonglycosylated hepatitis B surface antigen in yeast cells, a process that was more cost-effective and scalable than the plasma-derived method. (uw.edu)
The antigen is harvested and purified from fermentation cultures of a recombinant strain of the yeast Saccharomyces cerevisiae containing the gene for the adw subtype of HBsAg. (theodora.com)
Despite widespread uses of tetanus toxoid (TT) as a vaccine, model antigen and protein carrier, TT epitopes have been poorly characterized. (listlabs.com)

Viral vector vaccines use genetic material, which gives your cells instructions for making a protein of the germ. (medlineplus.gov)
Non-replicating vaccines based on recombinant viral vectors which have been given the ability to replicate, which means that these vectors is sufficient to induce a host immune response, but they can not replicate in the host cell. (medicaltrend.org)
MV-LASV vaccine candidate is a recombinant, live-attenuated, viral vectored vaccine. (precisionvaccinations.com)
rVSV-ZEBOV is a live-attenuated recombinant viral vaccine. (msdmanuals.com)
For example, by the spike protein found on the surface of the COVID-19 virus, viral vectors are able to help the body recognize the disease and fight against it. (verv.com)

Hippocrates clinically described it, and, in the 20th century, diphtheria evolved from a major public health problem to a medical curiosity within the developed nations through the use of immunization measures. (medscape.com)
Fortunately, the widespread immunization of infants using diphtheria toxoid has made this infection extremely rare in developed nations. (medscape.com)
After diphtheria immunization was introduced, the number of cases gradually fell to about 19,000 in 1945. (medscape.com)
When diphtheria immunization became widespread in the late 1940s, a more rapid decrease in the number of cases and deaths occurred. (medscape.com)

MV-CHIK consists of a recombinant live Schwarz-strain measles-vectored vaccine expressing chikungunya virus structural proteins. (precisionvaccinations.com)

2. Adolescent Immunizations: Vaccines recommended for adolescents, including vaccinations for human papillomavirus (HPV), meningococcal meningitis, and tetanus-diphtheria-pertussis booster shots. (cims.org)

4. Toxoid Vaccines: These vaccines contain inactivated toxins produced by certain bacteria. (cims.org)

These types of vaccines are called recombinant vaccines. (medicaltrend.org)

Conjugate vaccines are made by combining polysaccharide residues in the bacterial surface capsule with carrier proteins (such as diphtheria toxoid protein). (medicaltrend.org)
However, the combination of the bacterial part and the carrier protein induces a powerful and comprehensive immune response. (medicaltrend.org)

The primary pathological lesion of diphtheria is the development of a thick leathery membrane consisting of bacteria, dead cells from the mucous membranes, and fibrin. (medscape.com)

mRNA-1653 is a combination vaccine that consists of two distinct mRNA sequences encoding the fusion (F) proteins of hMPV and PIV3 formulated in Moderna's proprietary lipid nanoparticle (LNP) technology. (precisionvaccinations.com)

A vaccine typically contains an agent that resembles a disease-causing microorganism and is often made from weakened or killed forms of the microbe, its toxins, or one of its surface proteins. (wikipedia.org)
A Vaccine is a special preparation that contains the killed or weak form of a disease-causing agent, its toxins, or its surface proteins, and when injected inside the body, it leads to the formation of antibodies that provide immunity against that specific organism. (pcweb.info)

Vaccine errors threaten to undermine the protection immunizations provide and often leave patients inadequately protected against serious diseases such as hepatitis A and B, pertussis, diphtheria, cervical cancer, and many others. (ismp.org)

MK-7110 (CD24Fc) COVID-19 Therapeutic candidate is a first-in-class recombinant fusion protein that targets the innate immune system. (precisionvaccinations.com)

Conjugation with a protein carrier improves the effectiveness of polysaccharide vaccines by inducing T-lymphocyte-dependent immunologic function ( 2 ). (cdc.gov)
It was found that efficiency of glycosylation but not carrier protein expression was highly susceptible to the physiological state at induction. (biomedcentral.com)
After induction glycoconjugates generally appeared later than unglycosylated carrier protein, suggesting that glycosylation was the rate-limiting step for synthesis of conjugate vaccines in E. coli . (biomedcentral.com)
a: oligosaccharyltransferase PglB, b: carrier protein with signal sequence for secretion to the periplasm, c: undecaprenyl-pyrophosphate-linked polysaccharides. (biomedcentral.com)
Carrier proteins. (lookformedical.com)

Glycoconjugate synthesis, in particular expression of oligosaccharyltransferase PglB, strongly inhibited growth of E. coli cells after induction, making it necessary to separate biomass growth and recombinant protein expression phases. (biomedcentral.com)

mRNA vaccines use messenger RNA, which gives your cells instructions for how to make a protein (or piece of a protein) of the germ. (medlineplus.gov)
Other vaccinations include instructions for your cells to produce a germ protein. (verifiedmarketresearch.com)

Also included under the category of non-live vaccines are toxoids, which generate an antibody response to toxins produced by a microbe rather than to the microbe itself. (cdc.gov)

M-001 vaccine is a recombinant protein containing 9 conserved epitopes from Influenza A and B that are common to the vast majority of influenza viruses. (precisionvaccinations.com)

The immune system responds by learning to destroy anything showing that protein: if the real virus arrives, the immune system will attack it immediately. (acm.org)
And the biggest question of all: How does the immune system record the structure of the foreign protein, how does it recognize the invader, and how is the immune response cranked up? (acm.org)

In vivo enzymatic coupling using the general glycosylation pathway of Campylobacter jejuni in recombinant Escherichia coli has been suggested as a simpler method for producing conjugate vaccines. (biomedcentral.com)
The presented data demonstrate that glycosylated proteins can be produced in recombinant E. coli at a larger scale. (biomedcentral.com)
Known hypersensitivity to E coli -derived proteins, Kineret, or to any component of the product. (drugs.com)

Composed of DNA or RNA (aka genetic code and coated with protein, viruses work by invading the body's healthy cells, making copies of themselves, and then invading more cells in the body. (verv.com)

Multiple forms, primary structure, and glycosylation of the mature protein. (kiev.ua)

Examples include the diphtheria and tetanus vaccines. (cims.org)

The mRNA instructs the cells to produce masses of the same spike protein that also occurs on the shell of the real coronavirus. (acm.org)
Will it produce the spike protein forever? (acm.org)

Although studies suggested these vaccines were efficacious in conventional HBV vaccine nonresponders and overall more immunogenic than yeast-derived recombinant vaccines, manufacturing costs were higher, and they were not widely used. (uw.edu)
HBsAg is produced in recombinant yeast cells. (theodora.com)
A portion of the hepatitis B virus gene, coding for HBsAg, is cloned into yeast, and the vaccine for hepatitis B is produced from cultures of this recombinant yeast strain according to methods developed in the Merck Research Laboratories. (theodora.com)
The HBsAg protein is released from the yeast cells by mechanical cell disruption and detergent extraction, and purified by a series of physical and chemical methods, which includes ion and hydrophobic chromatography, and diafiltration. (theodora.com)
The vaccine contains no detectable yeast DNA, and 1% or less of the protein is of yeast origin. (theodora.com)

Moderna mRNA-1893 vaccine contains an mRNA sequence encoding for the structural proteins of the Zika virus and is designed to cause cells to secrete virus-like particles. (precisionvaccinations.com)

When the virulent version of an agent is encountered, the body recognizes the protein coat on the agent, and thus is prepared to respond, by first neutralizing the target agent before it can enter cells, and secondly by recognizing and destroying infected cells before that agent can multiply to vast numbers. (wikipedia.org)

The name diphtheria is derived from the Greek root for leather, which is descriptive for the pharyngeal membrane that characterizes the disease. (medscape.com)

Huppertz B, Meiri H, Gizurarson S, Osol G, Sammar M. Placental protein 13 (PP13): a new biological target shifting individualized risk assessment to personalized drug design combating pre-eclampsia. (hi.is)

In most developed countries with access to recombinant product, prophylaxis is primary (ie, therapy is started in patients as young as 1 y and continues into adolescence). (medscape.com)

Organisms4

Diseases3

Chemicals and Drugs30

Analytical, Diagnostic and Therapeutic Techniques and Equipment7

Phenomena and Processes5

Technology, Industry, Agriculture3

Information Science3

Health Care2

Geographicals3

Toxin22

Subunit4

Antigens6

Haemophilus8

Tetanus and diphtheria3

Antigen4

Viral5

Immunization4

Measles1

Human papillomavirus1

Vaccines contain1

Types of vaccines1

Bacterial2

Bacteria1

MRNA sequences1

Surface proteins2

Diseases1

Fusion protein1

Carrier5

Synthesis1

Germ2

Toxins produced1

Epitopes1

Immune2

Coli3

Body's1

Glycosylation1

Examples1

Spike protein2

Yeast5

Vaccine contains1

Cells1

Disease1

Biological1

Product1